Website Header with Language Selector and Dropdowns
Image

Alimemazine Dimer Impurity


Catalog Number: Cl-ALMZ-07
CAS No.: NA
Mol.F: C30H29N3S2
Mol.W: 495.7
Inv. Status: Custom Synthesis

Chemical Name: (R)-3-(10H-[3,10'-biphenothiazin]-10-yl)-N,N,2-trimethylpropan-1-amine.

Country of Origin: India

Product Category: Alimemazine Impurities


Alimemazine Dimer Impurity is identified by CAS No. NA and is chemically known as (R)-3-(10H-[3,10'-biphenothiazin]-10-yl)-N,N,2-trimethylpropan-1-amine.

Alimemazine Dimer Impurity is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Alimemazine.

Page Keywords: Buy Alimemazine Dimer Impurity | Purchase Alimemazine Dimer Impurity | Alimemazine Dimer Impurity suppliers | Alimemazine Dimer Impurity manufacturers | Alimemazine Dimer Impurity price | Alimemazine Dimer Impurity Importer | Alimemazine Dimer Impurity Exporter

Enquiry Now

Personal Details

Product Details

Related Products

CAT No: Cl-ALMZ-06
CAS No: 84-96-8
Mol Wt: 298.4
Mol F: C18H22N2S
Inv. Status: Custom Synthesis
CAT No: Cl-ALMZ-01
CAS No: 4330-99-8
Mol Wt: 298.4 : 1/2(150.1)
Mol F: C18H22N2S : 1/2(C4H6O6)
Inv. Status: Custom Synthesis
CAT No: Cl-ALMZ-05
CAS No: NA
Mol Wt: 495.7
Mol F: C30H29N3S2
Inv. Status: Custom Synthesis
CAT No: Cl-ALMZ-02
CAS No: 10071-07-5
Mol Wt: 314.4
Mol F: C18H22N2OS
Inv. Status: Custom Synthesis
CAT No: Cl-ALMZ-03
CAS No: 22732-04-3
Mol Wt: 284.4
Mol F: C17H20N2S
Inv. Status: Custom Synthesis
CAT No: Cl-ALMZ-04
CAS No: 92-84-2
Mol Wt: 199.3
Mol F: C12H9NS
Inv. Status: Custom Synthesis
CAT No: Cl-ALMZ-09
CAS No: 84-08-2
Mol Wt: 296.4
Mol F: C18H20N2S
Inv. Status: Custom Synthesis
CAT No: Cl-ALMZ-08
CAS No: 1175-88-8
Mol Wt: 298.4 : 150.1
Mol F: C18H22N2S : C4H6O6
Inv. Status: Custom Synthesis
Subscribe for news letter:
  

© Cleanchem Laboratories LLP. All Rights Reserved.